Qualigen Therapeutics Inc
NASDAQ:AIXC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Qualigen Therapeutics Inc
NASDAQ:AIXC
|
US |
|
Hemnet Group AB (publ)
OTC:HMNTY
|
SE |
|
Banca Sistema SpA
MIL:BST
|
IT |
|
Remedy Entertainment Oyj
OTC:RMDEF
|
FI |
|
B
|
Babcock International Group PLC
F:BW3
|
UK |
|
ELMO Software Ltd
ASX:ELO
|
AU |
Shareholder Yield
Current shareholder yield for 
AIXC is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
AIXC Price
Qualigen Therapeutics Inc
| Average Annual Return | -66.29% |
| Standard Deviation of Annual Returns | 26.03% |
| Max Drawdown | -100% |
| Market Capitalization | 4.7m USD |
| Shares Outstanding | 20 230 000 |
| Percentage of Shares Shorted | 0.8% |
AIXC Return Decomposition
Main factors of price return
Stock Splits
AIXC's latest stock split occurred on Nov 5, 2024
The company executed a 1-for-50 stock split, meaning that for every 50 shares held, investors received 1 new share.
Before the split, AIXC traded at 0.101 per share. Afterward, the share price was about 5.08.
The adjusted shares began trading on Nov 5, 2024. This was stock split number 4 in AIXC's history, following the previous one in Nov 23, 2022.
